Pharmaceutical firms, biotechnology companies and medical device manufacturers are subject to rigorous compliance standards set forth by regulatory agencies across all countries where they operate.

$
Billion

$39B expected R&D spend by medical tech firms by 2024.*

The U.S. FDA and other global standards organizations continually add stringent requirements for record keeping, document control and collaboration and software validation.

Compliance with